Compare LATA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LATA | INFU |
|---|---|---|
| Founded | 2025 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.8M | 270.1M |
| IPO Year | 2025 | 2005 |
| Metric | LATA | INFU |
|---|---|---|
| Price | $10.22 | $13.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.83 |
| AVG Volume (30 Days) | 58.3K | ★ 124.0K |
| Earning Date | 01-01-0001 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | N/A | $6.16 |
| P/E Ratio | ★ N/A | $68.00 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $9.91 | $7.29 |
| 52 Week High | $10.22 | $13.85 |
| Indicator | LATA | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 71.43 | 71.25 |
| Support Level | $10.17 | $8.77 |
| Resistance Level | N/A | $13.85 |
| Average True Range (ATR) | 0.00 | 0.39 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 100.00 | 95.82 |
Galata Acquisition Corp II is a blank check company.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.